April 28, 2021 14 min read
Polycystic ovary syndrome (PCOS) is the most common hormone disorder in women of reproductive age, affecting 5–15% of women as early as the second decade of life (1).
As the exact causes of the disorder remain unknown, it is diagnosed based upon consensus criteria and the exclusion of other endocrine disorders (see table below), with the Rotterdam criteria most commonly used for diagnosis (2).
PCOS is characterized by hyperandrogenism and oligo-ovulation or anovulation, resulting in acne, hirsutism (excessive growth of dark or coarse hair in a male-like pattern), male-pattern hair loss, irregular menstrual cycles, and subfertility (3).
In addition to the endocrine and reproductive effects, PCOS impacts cardiometabolic and psychological health across the lifespan (4).
Women with the disorder are more likely to develop obesity, type 2 diabetes, cardiovascular disease (CVD), non-alcoholic fatty liver disease (NAFLD), and have a greater risk of developing anxiety, depression, and mood disorders (5).
Table adapted from Shele et al. (5)
In women with PCOS, the ovaries are stimulated to produce excessive amounts of androgens; potentially through hyperstimulation by luteinizing hormone (LH) or the intrinsic dysregulation of steroidogenesis (6).
Besides contributing to the development of many features of the disorder, hyperandrogenism promotes insulin resistance and hyperinsulinemia, which can further aggravate hyperandrogenemia as well as lead to weight gain and obesity (7).
The mechanisms by which androgens specifically affect insulin dynamics are unknown. However, insulin resistance in women with PCOS has been attributed to impaired insulin signaling that affects the metabolic pathway (8).
Insulin resistance, hyperinsulinemia, overweight and obesity are common in women with PCOS and exacerbate the appearance of the disorder, partly by further stimulating steroidogenesis and androgen production (4).
PCOS is a challenging endocrine disorder to treat because of the reciprocal relationship between androgens and insulin, combined with the impact of each on the presentation of the features of PCOS and the unknown etiology of the disorder (9).
In addition to elevated levels of androgens and insulin, adipose-derived hormones are reported to be dysregulated in PCOS and may further contribute to metabolic dysfunction in women with the disorder (10).
How is PCOS diagnosed?
Diagnosis of PCOS is relatively straightforward from a medical perspective. Normal FSH and high levels of LH will show up on a blood test. This is consistent with the excess androgens in the condition; the imbalance between testosterone and estrogen. In addition, serum testosterone levels are usually increased.
A transvaginal ultrasound will show multiple cysts containing follicles in a usually enlarged ovary. There are typically at least 12 cystic follicles, ranging from 2mm to 9mm in size. However, there can be more than this, sometimes up to 50. A biopsy of the endometrium is sometimes indicated.
In addition to the above; additional screening tests are very useful as depicted below:
Role of Physical Activity in Managing PCOS Symptoms
One of the first lines of advice for managing PCOS symptoms is weight loss which should be coupled with a healthy, well-balanced diet (11). Women with PCOS are given the general advice to be physically active (9).
Studies have examined different types of exercise and exercise regimens in mitigating PCOS characteristics and improving health and outcomes in women with the disorder.
Considering the current body of evidence on the impact of various types of physical exercise on hormone health in women with PCOS, the following are recommended guidelines for healthcare providers and patients with PCOS:
Practical application – intense resistance training for PCOS
Intense resistance training diminishes intramuscular glycogen stores quite dramatically. Intense muscle contractions trigger acute changes in glucose and insulin function which help restore glycogen levels. This results in muscles being super-sensitive to glucose uptake after intense resistance exercise.
So essentially, this shuttles glucose into muscle tissue rather than having it float around in the bloodstream.
The culminating effect of this is increased insulin sensitivity and effective nutrient partitioning – two things that are not happening in PCOS.
Therefore, we can use resistance exercise to enhance insulin function.
In summary; physical exercise is part of the lifestyle recommendations for women with PCOS. Vigorous aerobic exercise, especially when practiced consistently over the long-term and in conjunction with heart rate and/or VO2max monitoring, can improve measures of insulin sensitivity.
Improvements in androgens are more likely with resistance or strength training, although further studies are warranted for confirmation. The impact of yoga on insulin sensitivity and androgens appears promising and requires additional research.
Optimizing management of PCOS with nutrition and supplementation
Quite often people with PCOS feel as if they are fighting a losing battle when it comes to achieving improvements in their body composition. However, the focus should always be on what they can do, not what they can’t, or what may hinder them.
Most women with PCOS, regardless of weight, have resistance to insulin. For this reason, changes in lifestyle that lead to improvements in insulin sensitivity should be considered as the first-line therapy in PCOS, especially in cases where there is the problem of excess weight and obesity (12).
In spite of the prevailing belief of the necessity to modify lifestyle factors, comprehensive information on nutritional recommendations for women with PCOS is not available. Let’s take a look at what has been done in order to glean the most essential information possible to help women with PCOS.
Obesity and weight loss in PCOS
There is a clear connection between PCOS and obesity. The average obese population with PCOS is higher than the average of obesity among healthy women. Obesity, especially abdominal obesity in adolescence and adulthood along with weight gain in puberty are predictors of hirsutism and menstrual disorders in this syndrome (13).
Obesity may increase risk of certain PCOS features such as increased levels of androgens, hirsutism, infertility, and pregnancy complications, such as preeclampsia and gestational diabetes. In addition, the obesity associated with insulin resistance increases risk of cardiovascular diseases and type 2 diabetes in women (14).
Several studies have reported the positive effects of 5–10 percent weight loss on reducing the risk factors for cardiovascular disease, type 2 diabetes, endocrine and reproductive parameters in polycystic ovary syndrome (15).
Disorderliness in appetite regulation is also observed among these women that may cause some problems with weight control. Levels of ghrelin and cholecystokinin, hormones which play essential roles in regulating appetite, are also impaired in these patients (16).
A successful weight loss strategy in this population is obtained through reduced calorie intake (500–1000 kcal per day) along with regular physical activity as well as stress reducing behavioral and psychological therapy, along with social support (17).
Macronutrient composition of weight-loss diets for PCOS
A recent meta-analysis (review of stats from multiple studies) of eight randomized controlled trials involving 327 patients was conducted to assess the effect of a low carbohydrate diet on women with PCOS.
The primary outcomes included changes in body mass index, homeostatic model assessment for insulin resistance (HOMA-IR), and blood lipids, including total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), follicle-stimulating hormone (FSH), luteotropic hormone (LH), total testosterone (T), and sex hormone-binding globulin (SHBG).
Based on the current evidence, low carbohydrate diet, particularly long-term low carbohydrate diet and low-fat/low-CHO low carbohydrate diet may be recommended for the reduction of body mass index, treatment of PCOS with insulin resistance, prevention of high LDL-C, increasing the levels of FSH and SHBG, and decreasing the level of T level.
Collectively, the analyzed data indicate that proper control of carbohydrate intake provides beneficial effects on some aspects of PCOS and may represent one of the important interventions improving the clinical symptoms of affected patients (18).
When we talk about carbohydrate, a common term to be familiar with is the glycemic index.
The glycemic index is a number from 0 to 100 assigned to a food, with pure glucose arbitrarily given the value of 100, which represents the relative rise in the blood glucose level two hours after consuming that food.
There is abundant evidence supporting the advantages of diets with a low glycemic index. This type of diet can improve insulin resistance (19) while foods with a high glycemic index exert opposite effects.
Research has also shown that a low glycemic index diet is associated with reduced of cardiovascular disease, type 2 diabetes, insulin resistance, and metabolic syndrome, as well as a reduced risk of endometrial, breast, and ovarian cancers (20).
Consequently, it seems that the type of carbohydrate intake has a more important role in maintaining metabolic health rather than the total amount received.
Practical application - Carb timing and meal frequency can help
For women with PCOS, consuming the appropriate amount of carbohydrates, at appropriate times is important because it ensures more effective nutrient partitioning. This means glucose will be delivered into muscles to restore glycogen levels and help with protein synthesis/recovery rather than being shuttled to fat cells.
Intense exercise creates a dramatic short-term shift in insulin sensitivity and glucose uptake. Consuming higher glycemic index carbs within this period optimizes results and prevents excess blood glucose levels outside of this time period.
Sub-optimal carb timing can contribute to hyperglycemia at unsuitable times, consequently worsening insulin sensitivity, which we know is the underlying mechanism of PCOS.
Another powerful intervention is meal frequency. Adequate meal frequency stabilizes insulin levels and enhances baseline metabolic rate. Both of these result in greater fat loss and more efficient insulin function.
In addition, there is a steady supply of amino acids from frequent feedings which further enhances insulin function and protein synthesis. When combined with a a solid exercise program, this leads to increased lean muscle tissue which will greatly benefit women with PCOS.
Fatty acids and PCOS
Diets high in fat, especially saturated fat and trans-fatty acids reduce insulin sensitivity and increase the risk of type 2 diabetes, metabolic syndrome, and cardiovascular disease (21), while consuming foods containing unsaturated fats reduces the risk of chronic diseases.
This is true especially for the diets containing unsaturated fatty acids and omega-3 that may decrease many risk factors for metabolic disorders seen in women to PCOS, such as high levels of serum lipids, insulin resistance and impaired endothelial function (22).
Until recently, no comprehensive evidence has investigated the effects of omega-3 consumption on PCOS complications. Therefore, a recent comprehensive review polyunsaturated fatty acid investigated the possible effect and related mechanisms (23).
Omega-3 polyunsaturated fatty acids are a promising agent in relieving complications associated with PCOS. There are multiple mechanisms by which omega-3 polyunsaturated fatty acids may exert their beneficial effects on PCOS women. These include anti-obesity, glycemic and hormonal homeostasis, anti-inflammatory, regulation of adipokine production and enhancement of endothelial function (see figure below).
Figure adapted from Salek et al. 2019 (23)
Although studies investigating omega-3 supplements in patients with PCOS reported an improvement in numerous complications and comorbidities, including insulin resistance, dyslipidemia, hyperandrogenism, and regulation of metabolic indicators; there is a distinct shortage of studies investigating the dietary intake of these types of fatty acids (23).
Vitamin D deficiency and PCOS
Research has demonstrated that vitamin D plays roles in various metabolic pathways, including insulin metabolism. Vitamin D deficiency affects the pathogenesis of insulin resistance and PCOS (24).
A recent review proposed an association between vitamin D status and hormonal and metabolic disorders among PCOS cases (25).
The mechanism behind this effect is still unknown, but a possible role for ovarian dysfunction in the mechanisms that regulate apoptosis (programmed cell death) has been reported. Moreover, due to its immune-enhancing role, lack of vitamin D may cause inflammatory responses leading to insulin resistance (26).
Several studies have reported low levels of vitamin D in PCOS. Hence, supplementation with vitamin D may be effective in modifying hormones and metabolism in these patients.
Minerals and PCOS
Reduced levels of magnesium have been reported in women with high levels of testosterone or insulin resistance. Therefore, magnesium replacement seems to be useful in the adjustment and improvement of insulin resistance.
Furthermore, decreased plasma levels of chromium have been reported in people with type 2 diabetes, suggesting that chromium deficiency may reduce insulin sensitivity (27).
A study where 1000 mcg of chromium picolinate was given to women with PCOS for 2 months resulted in improved glucose levels and insulin sensitivity (28).
In addition, chromium picolinate is involved in reducing hirsutism and alleviating the symptoms of PCOS (29).
Amongst the few studies available on PCOS patients, chromium supplementation has been reported to lead to significant reduction of body mass (30).
Also, low selenium levels in PCOS women compared with healthy controls have been reported and expressed a negative correlation between serum testosterone level and selenium (31).
Caffeine and PCOS
Caffeine is a dietary concern relevant to polycystic ovaries in women, which affects ovulation and corpus luteum function through changing hormone levels. Most studies have established that caffeine intake is a risk factor for reduced fertility. Results of a study showed that taking more than 500 mg of caffeine per day increases the risk of infertility (32).
There is some evidence which proposes that there is an association between caffeine intake and the elevated risk of spontaneous abortion (33).
A meta-analysis study revealed a significant relationship between moderate to high doses of caffeine intake with abortion and low birth weight (34).
Although not all studies have confirmed these findings, women with PCOS are recommended to take special precautions to avoid receiving very high doses of caffeine.
The relationship between PCOS and insulin resistance presents an opportunity to intercede in the dietary habits of women with this condition to prevent or delay the onset of type 2 diabetes and cardiovascular disease.
It’s clear that nutritional management and exercise should focus on weight loss plans. Special attention should be given to the impact of the various components of the diet and proper exercise programming in order to improve insulin sensitivity.
Two supplements that could help this condition are One+ and ADA Load
One+ combines 23 vitamins and minerals to provide what your body may be lacking. Since insulin resistance is a prominent feature of PCOS, doing what we can to enhance insulin sensitivity and get blood glucose levels under control is paramount. ADA Load is a potent combination of ingredients shown in evidence-based research to reduce blood sugar levels in individuals with high blood glucose.
In addition, a beneficial dietary plan in women with PCOS should contain low amounts of saturated fatty acids with average amounts of unsaturated fatty acids including omega-3.
Also, sufficient intake of fiber-rich diet from whole grains, legumes, vegetables and fruits with an emphasis on carbohydrate sources with low glycemic index is highly recommended.
While improving the symptoms of PCOS, the recommendations above may also reduce the risk of developing chronic diseases associated with insulin resistance (e.g., type 2 diabetes).
1.Welt, C. K., and Carmina, E. (2013) Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. J Clin Endocrinol Metab 98, 4629-4638
2.Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., Witchel, S. F., Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen, E., and Society, P. (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91, 456-488
3.Franks, S. (1995) Polycystic ovary syndrome. N Engl J Med 333, 853-861
4.Moran, L. J., Norman, R. J., and Teede, H. J. (2015) Metabolic risk in PCOS: phenotype and adiposity impact. Trends Endocrinol Metab 26, 136-143
5.Shele, G., Genkil, J., and Speelman, D. (2020) A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome. J Funct Morphol Kinesiol 5
6.Barnes, R. B. (1998) The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies. J Endocrinol Invest 21, 567-579
7.Nestler, J. E. (1997) Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. Semin Reprod Endocrinol 15, 111-122
8.Corbould, A., Zhao, H., Mirzoeva, S., Aird, F., and Dunaif, A. (2006) Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes 55, 751-759
9.Bates, G. W., and Legro, R. S. (2013) Longterm management of Polycystic Ovarian Syndrome (PCOS). Mol Cell Endocrinol 373, 91-97
10.Behboudi-Gandevani, S., Ramezani Tehrani, F., Bidhendi Yarandi, R., Noroozzadeh, M., Hedayati, M., and Azizi, F. (2017) The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines. J Endocrinol Invest 40, 859-866
11.Artini, P. G., Di Berardino, O. M., Simi, G., Papini, F., Ruggiero, M., Monteleone, P., and Cela, V. (2010) Best methods for identification and treatment of PCOS. Minerva Ginecol 62, 33-48
12.Norman, R. J., Davies, M. J., Lord, J., and Moran, L. J. (2002) The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 13, 251-257
13.Zeinab Faghfoori, S. F., Mahdi Shadnoush, Reza Goodarzi. (2017) Nutritional management in women with polycystic ovary syndrome: A review study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 11, S429-S432
14.Motta, A. B. (2012) The role of obesity in the development of polycystic ovary syndrome. Curr Pharm Des 18, 2482-2491
15.Panidis, D., Farmakiotis, D., Rousso, D., Kourtis, A., Katsikis, I., and Krassas, G. (2008) Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Fertil Steril 89, 899-906
16.Moran, L. J., Noakes, M., Clifton, P. M., Wittert, G. A., Le Roux, C. W., Ghatei, M. A., Bloom, S. R., and Norman, R. J. (2007) Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome. Am J Clin Nutr 86, 1603-1610
17.Moran, L. J., Brinkworth, G. D., and Norman, R. J. (2008) Dietary therapy in polycystic ovary syndrome. Semin Reprod Med 26, 85-92
18.Zhang, X., Zheng, Y., Guo, Y., and Lai, Z. (2019) The Effect of Low Carbohydrate Diet on Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials. Int J Endocrinol 2019, 4386401
19.Ebbeling, C. B., Leidig, M. M., Sinclair, K. B., Seger-Shippee, L. G., Feldman, H. A., and Ludwig, D. S. (2005) Effects of an ad libitum low-glycemic load diet on cardiovascular disease risk factors in obese young adults. Am J Clin Nutr 81, 976-982
20.Krishnan, S., Rosenberg, L., Singer, M., Hu, F. B., Djousse, L., Cupples, L. A., and Palmer, J. R. (2007) Glycemic index, glycemic load, and cereal fiber intake and risk of type 2 diabetes in US black women. Arch Intern Med 167, 2304-2309
21.Stender, S., and Dyerberg, J. (2004) Influence of trans fatty acids on health. Ann Nutr Metab 48, 61-66
22.Zivkovic, A. M., German, J. B., and Sanyal, A. J. (2007) Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 86, 285-300
23.Salek, M., Clark, C. C. T., Taghizadeh, M., and Jafarnejad, S. (2019) N-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications. EXCLI J 18, 558-575
24.Ngo, D. T., Chan, W. P., Rajendran, S., Heresztyn, T., Amarasekera, A., Sverdlov, A. L., O'Loughlin, P. D., Morris, H. A., Chirkov, Y. Y., Norman, R. J., and Horowitz, J. D. (2011) Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin D. Nitric Oxide 25, 326-330
25.Thomson, R. L., Spedding, S., and Buckley, J. D. (2012) Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 77, 343-350
26.Bikle, D. (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94, 26-34
27.Morris, B. W., MacNeil, S., Hardisty, C. A., Heller, S., Burgin, C., and Gray, T. A. (1999) Chromium homeostasis in patients with type II (NIDDM) diabetes. J Trace Elem Med Biol 13, 57-61
28.Lydic, M. L., McNurlan, M., Bembo, S., Mitchell, L., Komaroff, E., and Gelato, M. (2006) Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome. Fertil Steril 86, 243-246
29.Jamilian, M., Bahmani, F., Siavashani, M. A., Mazloomi, M., Asemi, Z., and Esmaillzadeh, A. (2016) The Effects of Chromium Supplementation on Endocrine Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial. Biol Trace Elem Res 172, 72-78
30.Amooee, S., Parsanezhad, M. E., Ravanbod Shirazi, M., Alborzi, S., and Samsami, A. (2013) Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: A double-blind randomized clinical trial. Iran J Reprod Med 11, 611-618
31.Coskun, A., Arikan, T., Kilinc, M., Arikan, D. C., and Ekerbicer, H. C. (2013) Plasma selenium levels in Turkish women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 168, 183-186
32.Stanton, C. K., and Gray, R. H. (1995) Effects of caffeine consumption on delayed conception. Am J Epidemiol 142, 1322-1329
33.Tolstrup, J. S., Kjaer, S. K., Munk, C., Madsen, L. B., Ottesen, B., Bergholt, T., and Gronbaek, M. (2003) Does caffeine and alcohol intake before pregnancy predict the occurrence of spontaneous abortion? Hum Reprod 18, 2704-2710
34.Fernandes, O., Sabharwal, M., Smiley, T., Pastuszak, A., Koren, G., and Einarson, T. (1998) Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: a meta-analysis. Reprod Toxicol 12, 435-444